Liver cancer is a malignant growth that happens in the liver. The liver is the biggest glandular organ in the body and plays different basic roles to liberate the body from poisons and hurtful substances. The liver is situated in the right upper quadrant of the midsection, i.e., abdomen, right beneath the ribs. It is responsible for bile production, a substance that assists in processing fats, nutrients, and different supplements. This imperative organ likewise stores supplements, for example, glucose which is utilized for energy. It again separates toxins and medications. When malignant growth creates in the liver, it obliterates liver cells and slows down the capacity of the liver to work typically.
There are various types of liver cancer. The liver can develop a variety of cancers. Hepatocellular carcinoma is the most frequent type of liver cancer. It starts in the primary type of liver cell (hepatocyte). Other kinds of liver cancer are significantly less prevalent, such as intrahepatic cholangiocarcinoma and hepatoblastoma.
Broadly, there are two types of liver cancer.
-
- Primary liver cancer
- Secondary liver cancer
Stages of Liver Cancer
Following stages are included in liver cancer:
Stage I: One cancer tumor is found in the liver only, as it were.
Stage II: One cancer tumor is found, yet it has spread to the veins, OR more than one tumor growth is available, yet they are primarily smaller than 3 cm.
Stage III: In Stage III, malignant liver growth, there is more than one tumor growth, and one of them is larger than 5 centimeters, OR the disease has moved past the liver to larger veins, another organ, or the lymph nodes.
Stage IV: The disease has spread to several different parts of the body, like the lungs or bones, as well as lymph nodes.
Liver malignant growth that has returned may likewise be called recurrent. The recurrent liver disease could return to the liver or elsewhere in the body.
» Now, let’s discuss causes, symptoms, diagnosis and treatment options for liver cancer
Causes of Liver Cancer
Liver disease happens when liver cells foster changes (transformations) in their DNA. A cell’s DNA is the material that gives guidelines to each substance cycle in your body. DNA transformations cause changes in these directions. One outcome is that cells might start to outgrow control and, in the long run, grow – a mass of carcinogenic cells.
In some cases, the factors causing liver cancer are known, such as chronic hepatitis infections. However, sometimes, such people develop liver cancer with no underlying disease, and thus, the cause of cancer remains unknown. Autoimmune conditions or disorders can also damage the liver in some cases. In autoimmune diseases, healthy cells are mistakenly attacked by the immune system instead of harmful cells, which are supposed to be removed from the body. Among these autoimmune disorders can cause long-term inflammation in the liver, like cholangitis. This chronic inflammation can further lead to other types of damage.
Symptoms of Liver Cancer
Individuals with liver cancer might encounter no manifestations or symptoms, especially when the tumor is recognized early as a component of a screening program. When symptoms or indications of liver disease do happen, they might incorporate those depicted beneath. A sign is something that only the individual encountering it can recognize and express, like weakness, sickness, or torment. Or a symptom is something that others can distinguish and quantify, like a fever, rash, or a raised heartbeat. Together, symptoms, signs, and side effects can assist with portraying a clinical issue. The reason for an indication or warning might be an ailment that isn’t malignant growth. A few potential side effects showing liver cancer include:
- Tiredness and weakness(fatigue)
- Pain in the right shoulder or abdominal pain
- Nausea, feeling of sickness, and loss of appetite
- On the right side of the body and under the ribs, there is produced a hard lump, which could be a sign of largeness of liver or is a tumor
- Unexplained weight loss
- Yellowing of the skin and eyes (jaundice)
- Dark urine and pale bowel motions (urine may turn a dark, almost brown color due to the more than average amount of bilirubin present in the system. In contrast, stools may develop a pale or clay-like color because enough bile is not produced by the liver).
- Itchy skin (because bile salts build up underneath your skin)
- There is a build-up of fluids (ascites) which causes swollen abdomen
- Fever(high temperature) is a sign of jaundice. High temperature can also be a sign of inflammation or an infection. When the temperature is tall person feel cold and shivery.)
- Bleeding from the esophagus or stomach, mental confusion (hepatic encephalopathy), or any worsening of the condition, may also indicate cancer.
The liver cancer symptoms may vary as they are dependent on the location of cancer cells. Symptoms of liver cancer are often quite vague, such as feeling sick and loss of appetite.
Other symptoms
A few liver cancers make chemicals (hormones) that follow up on organs other than the liver. These hormones might cause:
-
- Low blood sugar levels (hypoglycemia), which can cause fatigue or fainting
- High counts of red blood cells (erythrocytosis) can cause someone to look red and flushed
- High blood calcium levels (hypercalcemia) can cause nausea, confusion, constipation, weakness, or muscle problems
- Breast enlargement (gynecomastia) andshrinkage of the testicles in men
- High cholesterol levels.
Diagnosis of Liver Cancer
- Blood tests: The amounts of certain substances linked to cancer are measured by a serum marker test. In the cases of liver cancer, thesubstance alpha-fetoprotein (AFP) shows higher levels. AFP in high levels is considered a tumor marker. Tests of liver enzymes that show higher than normal levels indicate liver diseases.
- Computed Tomography (CT scan):In this technique, the particular type of X-ray provides detailed images of organs.
- Laparoscopy:This technique involves using a thin tube with a light (laparoscope) to observethe liver and other organs present inside the stomach area.
- Magnetic Resonance Imaging (MRI):This testing technique produces clear images of the human body using a large magnet, radio waves, and a computer.
- Ultrasound (sonography):This test provides pictures of your soft tissue structures.
- Angiogram: This test is done by using a dye injected into an artery to show liver tissue and any tumors.
- Biopsy:The tissue removal for study under a microscope is known as a It may be done using a laparoscope. A biopsy is the most reliable way to determine cancer.
Risk factors of liver cancer
A risk factor doesn’t imply that you will foster an infection. However, it builds your possibilities of getting a sickness. there are definite factors that are known to produce the danger of creating malignant liver growth:
Old age. Liver disease is more common in individuals over age 50.
Chronic infection with HBV or HCV. The risk of liver cancer is increased when chronic infection with the hepatitis B virus (HBV) or hepatitis C virus (HCV) is present.
Cirrhosis. Cirrhosis is liver harm wherein normal healthy tissue is replaced by scarred tissue. A scarred liver can’t work as expected and may at last prompt various difficulties, including malignant liver growth. Long-term liquor overuse and hepatitis C are the most well-known reasons for cirrhosis.
Certain inherited liver diseases. Liver infections that can build the danger of malignant liver growth incorporate hemochromatosis and Wilson’s illness.
Excessive alcohol consumption. Consumption of alcohol more than a certain moderate amount daily and for quite a long time, i.e., over the years, consequently, leads to irreversible liver damage and increases the risk of liver cancer.
Nonalcoholic fatty liver disease. An accumulation of fat in the liver increases the risk of liver cancer.
Diabetes. People with this blood sugar disorder have a greater risk of liver cancer than those who don’t have diabetes.
Exposure to aflatoxins. Aflatoxins are poisonous substances or toxins produced by a type of mold that grows on crops stored poorly. Crops, such as grains and nuts, can become contaminated with aflatoxins, which then are present in foods made of these products.
Treatment of liver cancer
How is liver cancer treated? The treatment and chance of recovery (also called prognosis) of liver cancer disease may rely upon specific things. These include general health, working condition of the liver, the phase or stage of cancer, and alpha-fetoprotein levels.
Liver malignant growth might be dealt with utilizing at least one technique: surgery, different types of drug therapy, locoregional therapy, and even liver transplantation.
Surgical treatments
The surgical treatments involved or used for treating liver cancer may include:
- Partial hepatectomy: this treatment is carried out by removinga part of the liver including a smaller wedge or even an entire liver lobe.
- Total hepatectomy and liver transplant: In a liver transplant, the entire liver is removed from the body and replaced by another liver obtained from the donor. Patients whocan undergo liver transplants must have a tumor size smaller than 5 centimeters, or in case of several tumors, each of them should be smaller than 3 centimeters each. In other conditions, the chances of cancer reoccurrence or returning are very high, and such high-risk liver transplantation can’t be justified.
When a transplant is successful, it minimizes the risk of cancer reoccurrence and can even restore the liver’s normal functioning. However, sometimes the new organ is ‘rejected’ and attacked by the immune system, which considers it a foreign body.
Further, several drugs used to suppress the immune system’s rejection and help the body adjust to the newly transplanted liver may have adverse effects and leave the person susceptible to various infections that might be severe. Occasionally, such drugs also contributeto spreading the previously metastasized tumors.
Non-surgical treatments
Ablation therapy: Tumors are destroyed in the liver without taking them out. There are multiple ways to do this, like cryoablation, microwave, radiofrequency, and ethanol.
Chemotherapy: Cancer cells are killed or are stopped from production by using drugs. Thischemotherapy technique can be systemic,e., the injections or the pills used to travel through the whole body.
Targeted therapy:This treatment procedure involves using drugs that focus on the tissue or gene of cancer. It is quite different from chemotherapy.
Immunotherapy:Using drugs that immediately the body’s immune system to kill cancer cells. It, too, is different than chemotherapy.
Loco–regionaltherapy: Injecting beads that emit radiation into the blood vessel that maintains the malignant growth or tumor (i.e., radioembolization). This type of therapy also has another version known as hepatic artery chemoembolization. The chemotherapeutic drug and the beads are combined for artery blockage in this procedure.
Trans-arterial chemoembolization:For the initial treatment of loco-regional HCC and downstaging the surpassed tumors. It is known as TACE. It can be considered before RFA and HR as regarded a neoadjuvant therapy which either reduces the volume of tumor or can also target micrometastasis.
Prognosis
The prognosis for liver cancer is weak. Only 5% to 15% of patients are eligible for surgical removal, suitable only for early-stage patients. Due to reduced hepatic regenerative capacity, right hepatectomy typically without cirrhosiscarries a higher risk for postoperative complications than left hepatectomy.
Treatment options for more advanced stages include the following:
(a) Transarterial chemoembolization (TACE), which leads to a 23% improvement in the 2 -year survival compared to conservative therapy for intermediate stage HCC patients.
(b) Oral dosing with sorafenib, a kinase inhibitor and the most accepted option for late-stage cases. However, fewer than one-third of patients benefit from the treatment, and drug resistance is evident within six months of initiating the therapy.
References
[1] T. Longerich, “Hepatocellular carcinoma,” Pathologe. 2020, doi: 10.1007/s00292-020-00801-z.
[2] A. S. Khan and L. A. Dageforde, “Cholangiocarcinoma,” Surgical Clinics of North America. 2019, doi: 10.1016/j.suc.2018.12.004.
[3] W. J. S. de Villiers, “Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management???2 Volume Set, 7th Edition,” Shock, 2003, doi: 10.1097/00024382-200304000-00021.
[4] A. K. Singh, R. Kumar, and A. K. Pandey, “Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers,” Curr. Chem. Genomics Transl. Med., 2018, doi: 10.2174/2213988501812010009.
[5] J. Gao et al., “Risk factors of hepatocellular carcinoma – Current status and perspectives,” Asian Pacific Journal of Cancer Prevention. 2012, doi: 10.7314/APJCP.2012.13.3.743.
[6] T. D. Boyer, T. L. Wright, and M. P. Manns, Zakim and Boyer´s HEPATOLOGY. A textbook of liver disease. 2006.
[7] J. Bruix, M. Reig, and M. Sherman, “Evidence-Based Diagnosis, Staging, and Treatment of Patients with Hepatocellular Carcinoma,” Gastroenterology. 2016, doi: 10.1053/j.gastro.2015.12.041.
[8] W. Wang and C. Wei, “Advances in the early diagnosis of hepatocellular carcinoma,” Genes and Diseases. 2020, doi: 10.1016/j.gendis.2020.01.014.
[9] D. Anwanwan, S. K. Singh, S. Singh, V. Saikam, and R. Singh, “Challenges in liver cancer and possible treatment approaches,” Biochimica et Biophysica Acta – Reviews on Cancer. 2020, doi: 10.1016/j.bbcan.2019.188314.
[10] J. K. Heimbach et al., “AASLD guidelines for the treatment of hepatocellular carcinoma,” Hepatology, 2018, doi: 10.1002/hep.29086.
[11] Z. Ren, X. Ma, Z. Duan, and X. Chen, “Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma,” Analytical Cellular Pathology. 2020, doi: 10.1155/2020/8157406.